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Crystal structures are presented for two dihydrate polymorphs (DH-I and DH-
II) of the non-steroidal anti-inflammatory drug sodium (S)-naproxen. The
structure of DH-I is determined from twinned single crystals obtained by
solution crystallization. DH-II is obtained by solid-state routes, and its structure
is derived using powder X-ray diffraction, solid-state 13C and 23Na MAS NMR,
and molecular modelling. The validity of both structures is supported by
dispersion-corrected density functional theory (DFT-D) calculations. The
structures of DH-I and DH-II, and in particular their relationships to the
monohydrate (MH) and anhydrate (AH) structures, provide a basis to
rationalize the observed transformation pathways in the sodium (S)-naproxen
anhydrate–hydrate system. All structures contain Na+/carboxylate/H2O
sections, alternating with sections containing the naproxen molecules. The
structure of DH-I is essentially identical to MH in the naproxen region,
containing face-to-face arrangements of the naphthalene rings, whereas the
structure of DH-II is comparable to AH in the naproxen region, containing
edge-to-face arrangements of the naphthalene rings. This structural similarity
permits topotactic transformation between AH and DH-II, and between MH
and DH-I, but requires re-organization of the naproxen molecules for
transformation between any other pair of structures. The topotactic pathways
dominate at room temperature or below, while the non-topotactic pathways
become active at higher temperatures. Thermochemical data for the dehydra-
tion processes are rationalized in the light of this new structural information.
1. Introduction
The correlation of molecular-level structure with observed
physicochemical properties is a fundamental activity in the
chemical sciences. Our interest lies principally with pharma-
ceutical compounds, for which robust physicochemical
understanding is paramount (Connelly et al., 2011). According
to regulatory guidelines (ICH, 2000; US-FDA, 2007), phar-
maceutical companies are encouraged to search for alternative
solid forms of active pharmaceutical ingredients (APIs), and
to assess the risks associated with solid-state factors such as
potential polymorphic transformations. In this context,
hydrates have a particular importance because of the ubiqui-
tous nature of water in our environment. Investigation and
understanding of hydrates with pharmaceutical relevance, and
especially the transformations that occur between different
hydration states in anhydrate–hydrate systems, is therefore of
significant interest within pharmaceutical materials science
(Griesser, 2006; Zhang et al., 2004; Reutzel-Edens et al., 2003;
Roy et al., 2008).
In this paper we consider the non-steroidal anti-inflamma-
tory drug (NSAID) sodium (S)-naproxen (chemical structure
shown in Scheme 1 with applied labelling scheme). The
compound is known to exist as an anhydrate (AH), a mono-
hydrate (MH), two dihydrate polymorphs (DH-I and DH-II)
and a tetrahydrate (TH) (Di Martino et al., 2001, 2007; Kim &
Rousseau, 2004; Malaj et al., 2009; Raijada et al., 2013). A
thorough empirical study of the thermodynamic and kinetic
aspects of dehydration in the system has been reported by
Malaj et al. (2009). Those authors refer to the various phases
as ASN (= AH), MSN (= MH), CSN (= DH-I), DSN (= DH-
II) and TSN (= TH). We have also previously studied the
transformation pathways for the system using multi-
temperature dynamic vapour sorption (DVS) and variable-
temperature/humidity powder X-ray diffraction (PXRD), and
we have identified routes to isolate bulk samples of the various
phases (Raijada et al., 2013).
A summary of the transformation behaviour is shown in Fig.
1. For hydration of AH, different pathways are followed
depending on the temperature. At 25C/55% relative
humidity AH transforms to DH-II, while at 50C/50% relative
humidity AH transforms to MH. Hydration of MH proceeds
to DH-I, either at 25C/55% relative humidity or 50C/80%
relative humidity. These results are obtained from variable-
temperature/humidity PXRD experiments. Corresponding
behaviour is observed on dehydration of the dihydrate phases.
Malaj et al. (2009) have reported that DH-I transforms
sequentially to MH then to AH, while DH-II transforms
immediately to AH under isothermal dehydration conditions
in the temperature range 22–37C. We concur with these
results and have also found similar behaviour for dehydration
at lower temperature (5C) under vacuum (Raijada et al.,
2013). Thermogravimetric analysis (TGA) shows that both
DH-I and DH-II exhibit a plateau corresponding to MH
before proceeding to AH, but MH persists over a larger
temperature range for DH-I compared with DH-II (Malaj et
al., 2009; Raijada et al., 2013).
Our aim in this paper is to link the observed hydration/
dehydration behaviour to the molecular-level solid-state
structures. To date, crystal structures have been published for
AH (Kim et al., 2004) and MH (Kim et al., 1990). A structure
described as a heminonahydrate, NS4.5H2O, has also been
reported (Burgess et al., 2012), which is disordered and which
we have re-interpreted as TH (Bond et al., 2013). Structural
information for the polymorphic dihydrate, however, has so
far not been reported. We discuss the structures of the two DH
polymorphs in this paper, and show that they provide a clear
basis to understand the transformation behaviour of the
system. The structures presented here complete the (currently
known) structural landscape of the sodium naproxen anhy-
drate–hydrate system, and illustrate the value of a complete
structural picture for robust physicochemical understanding.
2. Experimental
2.1. Materials
Sodium (S)-naproxen anhydrate (AH; USP grade) was
obtained from Divi’s Laboratories Ltd, India. Methods for
preparation of the various bulk phases have been described
previously (Raijada et al., 2013). Single crystals of DH-I were
obtained by dissolving 500 mg of AH in 79 mol % EtOH
(4.62 ml EtOH + 0.38 ml H2O) at 60
C. The solution was
filtered to remove any undissolved residues of AH then
allowed to cool to room temperature. The first single crystals
to appear were transferred rapidly from the mother liquor to
perfluoropolyether oil, then into the N2 cryostream (at 150 K)
on the diffractometer. Several crystals from different batches
were examined, with comparable results.
2.2. X-ray diffraction
Single-crystal X-ray diffraction data were collected using a
Bruker–Nonius X8-APEXII instrument equipped with
graphite-monochromated Mo K radiation ( = 0.7107 A˚).
Data were collected at 150 K under an N2 cryostream in an
effort to minimize dehydration during the data collection.
Structure solution and refinement were carried out using
SHELXL (Sheldrick, 2008). Powder X-ray diffraction data
were collected using a Panalytical X’Pert Pro instrument
equipped with non-monochromated Cu K radiation (average
 = 1.5418 A˚). Data were collected in either flat-plate reflec-
tion or transmission capillary modes. Preliminary data analysis
was carried out using HighScorePlus (Panalytical, 2012), and
pattern indexing was achieved using DICVOL (Boultif &
Loue¨r, 2004). Rietveld refinements were performed with
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Figure 1
Summary of the transformation pathways for the sodium naproxen
anhydrate–hydrate system. Hydration is shown with normal text/arrows,
dehydration is shown with bold text/arrows.
TOPAS Academic, Version 4.1 (Coelho, 2007) using the
DASH (David et al., 2006) interface for construction of the
initial input files.
2.3. Solid-state 23Na and 13C MAS NMR
Solid-state MAS NMR spectra were recorded on a Bruker
Avance 400 spectrometer operating at Larmor frequencies of
100.62, 105.85 and 400.13 MHz for 13C, 23Na and 1H, respec-
tively, using a double-tuned CP/MAS probe. A 23Na MAS
NMR spectrum was also recorded for AH on a Bruker
Avance-II 700 spectrometer operating at 185.15 MHz.
Samples were loaded in sealed tubes to avoid dehydration.
The measurement temperature was 313 K. Detailed experi-
mental conditions are provided in the supporting information.
All data were initially processed using TOPSPIN 2.1 (Bruker,
2008) then transferred toMATLAB (Mathworks, 2000) to set
up figures. Numerical simulations and iterative fitting of the
experimental 23Na MAS spectra to extract isotropic chemical
shifts and quadrupolar parameters for 23Na were performed
using a modified version of the software described in Larsen et
al. (1998), assuming ideal RF-excitation. Additional experi-
mental methods are discussed in Bennett (1995), Brown
(1997), Delaglio (1995) and Peersen (1993).
2.4. Computational methods
Energy minimization of the crystal structures was carried
out by dispersion-corrected density functional theory (DFT-
D) calculations, using the CASTEPmodule (Clark et al., 2005)
within Materials Studio (Accelrys, 2011). The PBE functional
was applied (Perdew et al., 1996) with a plane-wave cut-off
energy of 520 eV and a dispersion correction according to
Grimme (2006). All other parameters were set to the ‘fine’
defaults within Materials Studio. All atomic coordinates and
unit-cell parameters were allowed to optimize within the
constraints of the crystal system. A validation study has
established that this methodology can be expected to repro-
duce the geometry of correct molecular crystal structures with
an average r.m.s. deviation of ca 0.08 A˚ for the non-H atoms
(van de Streek & Neumann, 2010).
3. Results and discussion
3.1. Crystal structures of AH and MH
The structures of AH (Kim et al., 2004) and MH (Kim et al.,
1990) are layered, containing Na+/carboxylate/(H2O) sections
alternating with sections containing the naproxen molecules
(Fig. 2). For consistent discussion of the structures, we refer to
the atomic sites as indicated in Scheme 1, and we transform
the published unit-cell setting for AH so that the layers lie
parallel to the (100) planes (see supporting information for
structures in CIF format). In AH (Fig. 2) the carboxylate
groups adopt two different coordination modes: Na+–(-O)–
Na+ and Na+–[O–C–O]–Na+. The latter define polymeric
ribbons along the crystallographic b axis. The Na+/carboxylate
sections are locally centrosymmetric. If the naproxen mole-
cules are deleted so that only the Na+ ions and carboxyl
groups remain, the structure can be described in space group
P21/c with one crystallographically distinct Na
+ ion and one
carboxylate group. Reduction of the symmetry to P21 arises
due to the naproxen molecules, which adopt an edge-to-face
type arrangement (Fig. 2). The two crystallographically
distinct naproxen molecules display slightly different mole-
cular conformations in the propionate side chain. In both
molecules, the naphthalene ring plane lies approximately
eclipsed with the C11—H11 bond when viewed in projection
along the C5—C11 bond (Fig. 3). Projection along the C11—
C12 bond shows that the carboxyl group in one molecule is
eclipsed with the C11—C13 bond, while it lies approximately
perpendicular to the C11—C5 bond in the other molecule
(Fig. 4). DFT-D minimization of the published AH crystal
structure results in an r.m.s. Cartesian displacement of 0.15 A˚
for the non-H atoms, which is consistent with expectations for
a correct room-temperature structure.
The MH structure (Fig. 2) contains one-dimensional poly-
meric ribbons along the crystallographic b axis, formed by
Na+–[O–C–O]–Na+ links, which are closely comparable to
those in AH (compare the b dimensions in Table 1). The
ribbons are paired through square-shaped Na+–(-O)2–Na
+
units, in which the -O linkages are provided by the carboxyl
groups. The water molecules project to either side, linking the
ribbons along the a axis through O—H  O hydrogen bonds.
The Na+/carboxylate/H2O sections contain local inversion
centres that intersect the crystallographic 21 screw axes so that
research papers
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Figure 3
Projection of the naproxen molecule approximately along the C5—C11
bond in AH and MH, showing two different orientations for the
naphthalene ring. H atoms (except H11) are omitted.
Figure 2
View of the structures of (a) AH and (b) MH along the b axis. Data are
taken from Kim et al. (1990, 2004).
the space group approximates P21/m. Again, the inversion
symmetry is broken by the naproxen molecules, which in this
case adopt a face-to-face type arrangement, with all naph-
thalene ring planes parallel. The Na+ coordination geometry
resembles square-based pyramidal, with Na+ lying out of the
approximate square plane. In contrast to AH, the ring planes
of the naproxen molecules lie approximately eclipsed with the
C11—C13 bond when viewed in projection along the C10—
C11 bond (Fig. 3). The orientation of the carboxyl group is
perpendicular to the C11—C5 bond, as shown for AH (mol. 2)
in Fig. 4. DFT-D minimization of the published MH crystal
structure results in an r.m.s. Cartesian displacement of 0.15 A˚
for the non-H atoms, which is again consistent with expecta-
tions for a correct room-temperature structure.
3.2. Solid-state 13C and 23Na NMR
13C CP/MAS NMR spectra have been reported previously
for AH after exposure to various degrees of humidity (Di
Martino et al., 2007) and 23Na MAS NMR have also been
reported for AH and MH (Burgess et al., 2012). Our 23Na
MAS spectra for all phases (Fig. 5) demonstrate that the
quadrupolar tensor of the 23Na site(s) is highly sensitive
towards the hydration state. The parameters in Table 2
(obtained by iterative fitting of the
experimental spectra; see supporting
information) show that the quad-
rupolar coupling constant CQ is
2.3 MHz or greater for AH and both
DH forms, while it is close to 1.0 MHz
for MH. The presence of two 23Na
sites in AH, as indicated by the crystal
structure (Kim et al., 2004), was
established by simultaneous iterative
fitting of spectra recorded at 9.4 and
16.4 T. A 3Q-MAS spectrum recorded
at 9.4 T did not resolve the two sites.
The two sites have essentially iden-
tical chemical shifts but different
quadrupolar parameters, in accor-
dance with previous reports (Burgess
et al., 2012). All of the other phases
show apparently only one 23Na site.
For DH-II an almost featureless 23Na
MAS lineshape suggests either a disordered structure or a
range of mutually exchanging configurations. The contours in
the 23Na 3Q-MAS spectrum (see supporting information)
mainly indicate a distribution in quadrupolar tensor para-
meters rather than a distribution of chemical shifts.
In the 13C CP/MAS NMR spectra (Fig. 5), AH exhibits two
resolved resonances for each of the sites C5, C6, C11 and C13
(labelling as in Scheme 1), whereas only one resonance is
observed for these sites in MH. This reveals the difference
between the molecular conformations in the region of the
propionate side chain (Figs. 3 and 4) and the edge-on
arrangement of the naproxen molecules in AH compared with
the parallel arrangement in MH. The 13C spectrum of DH-I is
similar to MH, indicating that the parallel arrangement of
naproxen molecules is also present in DH-I. However, the
resonances for the propionate side chain are noticeably
broader for DH-I, which may indicate some degree of struc-
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Table 2
23Na NMR isotropic chemical shifts (iso), quadrupolar coupling constants
(CQ) and asymmetry parameters (Q) for AH, MH, DH-I and DH-II.
iso (p.p.m.) CQ (MHz) Q Relative abundance
AH (site 1)† 2.7 3.17 0.57 0.55
AH (site 2)† 2.7 2.86 0.74 0.45
MH‡ 4.1 1.04 0.54 –
DH-I‡ 0.8 2.95 0.25 –
DH-II‡§ 1.7 2.30 0.49 0.5
0.0 2.50 0.40 0.5
Ibuprofen-DH 0.0 2.80 0.20 –
† Fitted to spectra recorded at 9.4 and 16.4 T. ‡ Fitted to spectra recorded at
9.4 T. § An approximate fit is based on the two listed sites.
Figure 4
Projection of the two crystallographically independent naproxen
molecules in AH approximately along the C11—C12 bond, showing
two different orientations for the carboxyl group. H atoms (except H11)
are not shown. The conformation in MH is comparable to that of AH
(mol. 2).
Table 1
Summary of the crystallographic information for AH, MH, DH-I and DH-II.
AH† MH DH-I DH-II




Formula weight 252.2 270.3 288.3 288.3
T (K) 298 291 150 298
Crystal system Monoclinic Monoclinic Triclinic Triclinic
Space group P21 P21 P1 P1
Z/Z0 4/2 2/1 2/2 4/4
a (A˚) 20.823 (6) 21.177 (6) 22.281 (9) 22.750 (6)
b (A˚) 5.9346 (16) 5.785 (2) 5.811 (2) 5.747 (3)
c (A˚) 9.969 (3) 5.443 (2) 5.435 (2) 10.866 (3)
 () 90 90 89.53 (2) 89.61 (4)
 () 102.025 (5) 91.41 (3) 85.53 (2) 98.20 (1)
 () 90 90 92.61 (1) 92.11 (6)
V (A˚3) 1204.9 (6) 666.6 (5) 700.8 (5) 1405.2 (8)
Density (g cm3) 1.391 1.346 1.366 1.363
† Unit cell transformed compared with Kim et al. (2004).
tural variation in this region. For DH-II, the 13C CP/MAS
spectrum resembles that of AH, thereby indicating an edge-on
arrangement for the naproxen molecules. Again, the lines are
slightly broader for DH-II compared with AH, which may
indicate some degree of disorder. It should be noted that the
NMR spectra in Fig. 5 are measured at 313 K, so they may be
influenced by dynamic phenomena.
3.3. Crystal structure of DH-I
Numerous solution-grown crystals of DH-I were examined,
and all displayed indications of twinning/disorder (discussed
further below). The structure was eventually obtained after
data integration using a single component in one crystal,
although subsequent structure refinement was problematic. In
particular, the data:parameter ratio is low (ca 4), on account of
limited observable data and the low symmetry of the structure,
and it was necessary to apply restraints to all bond distances
and angles in order to maintain a reasonable geometry. The
problems with the single-crystal analysis most likely also
reflect some degree of dehydration during the transfer of the
crystals from the mother liquor to the N2 cryostream and/or in
the course of the data collection. The validity of the estab-
lished structure is supported by DFT-D minimization, which
results in an r.m.s. Cartesian displacement of 0.14 A˚ for the
non-H atoms, comparable to that obtained for minimization of
AH and MH. Comparison to the PXRD pattern of the bulk
sample by Rietveld refinement also
provides a satisfactory fit (see
supporting information).
The structure of DH-I closely
resembles that of MH. In parti-
cular, the structures have very
similar unit cells (Table 1) and they
are essentially identical in the
regions of the naproxen molecules,
consistent with the information
deduced from the 13C CP/MAS
NMR spectra. The naproxen
regions exhibit local 21 symmetry,
and local inversion symmetry also
exists within the Na+/carboxylate/
H2O sections. The 21 symmetry is
broken by the Na+/carboxylate/
H2O sections and the inversion
symmetry is broken by the
naproxen molecules, so that the
crystallographic symmetry is
reduced to P1 with two formula
units in the asymmetric unit.
Similar examples of pseudosym-
metry have been noted in the
context of isostructural racemic
and enantiomeric crystals (Zhang
& Grant, 2005). The molecular
conformations of the two crystal-
lographically distinct naproxen molecules are closely
comparable, and identical to that in MH. The ring plane of the
naproxen molecule lies eclipsed with the C11—C13 bond (Fig.
3), and the carboxyl group is perpendicular to the C5—C11
bond (Fig. 4). As for AH andMH, the DH-I structure contains
one-dimensional polymeric ribbons along the b axis, cross-
linked by square-shaped Na+–(-OH2)2–Na
+ units. The
research papers
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Figure 6
Structure of DH-I. The view along the b axis (a) is along the direction of
propagation of the polymeric ribbon. The view along the c axis (b) shows
one square-shaped Na+–(-OH2)2–Na
+ unit and the square-pyramidal
coordination geometry of Na+.
Figure 5
Solid-state 13C CP/MAS (column A) and 23Na (column B) MAS NMR spectra measured at 313 K.
Resonance assignments are shown for AH and MH (labelling according to Scheme 1). The assignments
for DH-I and DH-II are clear by analogy. Spectra are also shown for sodium ibuprofen dihydrate (top),
which has a similar structure to DH-II in the Na+/H2O region (see text).
linking units are geometrically similar to those in AH, except
that the -O bridges in DH-I are formed by water molecules
(Fig. 6) rather than carboxyl O atoms. The non-bridging H2O
molecules form O—H  O hydrogen bonds between ribbons.
The Na+ coordination geometry is close to regular square-
based pyramidal, with Na+ in the square plane. Despite the
formal crystallographic inequivalence of the two Na+ sites, the
pseudosymmetry means that their local environments are
essentially identical, which can account for the observation of
a single site in the 23Na NMR.
3.4. Disorder and twinning in DH-I
Reconstructed precession images for DH-I (supporting
information) appear ordered for 0kl, 1kl etc., indicative of
regular two-dimensional layers in the structure parallel to the
(100) planes. The disorder is evident in the diffraction pattern
as reflections split along a*. The probable origin of this can be
viewed as a result of the pseudosymmetry. Combination of the
local 21 operator that relates the naproxen molecules
(1 x; 12þ y; 12 z) with the local inversion operator
(1 x; 1 y; 1 z) within the Na+/H2O sections generates a
mirror operator (x; 12 y; z). This local mirror can be applied
to the Na+/H2O section to reverse the orientation of the
square-shaped Na+–(-OH2)2–Na
+ units relative to the b axis
(Figs. 7 and 8). If this occurs, the next layer of naproxen
molecules is shifted by 12b compared with its expected position
in order to maintain identical chemical contacts (Fig. 7). A
‘fault’ of this kind corresponds to twinning of the structure by
180 rotation around the b axis. DFT-D minimizations of the
two models represented as red and blue in Fig. 7 converge to
identical minima, with the unit-cell orientations related to
each other by 180 rotation around b, confirming the
symmetry and energetic viability of this twinning mechanism.
Since the metric symmetry of DH-I is very close to mono-
clinic, the twinning is approximately merohedral (i.e. the
Bragg peaks in the twin components are approximately
overlapped). However, the  angle deviates sufficiently from
90 for the twinning to be apparent as split peaks in the
diffraction pattern, as described. Attempts at two-component
integration of the single-crystal data were not successful,
apparently due to the close overlap
of the diffraction peaks. Post-
analysis of the data integrated as a
single component using TWIN-
ROTMAT in PLATON (Spek,
2009) was able to identify the
twinning, and two-component
refinement using the generated
HKLF-5 format in SHELXL
(Sheldrick, 2008) gave a refined
batch scale factor of ca. 10%.
The applied preparation route
for DH-II, by direct hydration of
solid AH, prohibits the formation
of diffraction-quality single crystals,
and the DH-II structure was
therefore considered using a combined PXRD/modelling
approach. The 13C CP/MAS NMR spectra (Fig. 5) show that
the arrangement of the naproxen molecules in DH-II must be
very similar to AH, and the PXRD data for DH-II could be
indexed on the basis of a unit cell that closely resembled AH
(Table 1) to provide a very good Pawley fit. The bc plane of
this unit cell is related to DH-I by doubling of the c axis, which
is clearly required in order to accommodate the edge-on
arrangement of naproxen molecules seen in AH. The first step
to model the DH-II structure was therefore to create a
supercell from the DH-I structure by doubling of the c axis
(Fig. 9a). The resulting enlarged unit cell could be transformed
to the AH-type cell obtained from Pawley fitting by applica-
tion of the matrix [1 012 / 0 1 0 / 0 0 1]. The result corresponds
to a supercell of the DH-I structure described in the AH-type
cell setting (Fig. 9a).
Comparison with the AH structure showed that the
naproxen molecule positions in one of the polymeric ribbons
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Figure 7
Probable twinning mechanism in DH-I. The Na+/H2O section is mirrored perpendicular to b, with an
accompanying shift of 12b for the bottom layer of naproxen molecules. The resulting structure (blue) is
identical to the starting structure (red) rotated 180 around b.
Figure 8
Schematic illustration of the alternative orientations for the Na+–(-
OH2)2–Na
+ units in a Na+/H2O section in DH-I. The positions of the
water molecules do not change.
closely reproduced those in AH, but the second polymeric
ribbon should be shifted by 12b in order for the naproxen
molecules to adopt positions similar to those in AH (Fig. 9b).
Crucially, this shift is permitted by the fact that the water
molecules along the coordination polymers are distributed at
intervals of approximately 12b, as shown in Fig. 8. Thus, the shift
can be applied without changing the positions of the water
molecules and without disrupting the hydrogen-bond network.
Compelling evidence for the plausibility of the resulting
structure is that the Na+/carboxylate/H2O region overlays
essentially exactly the comparable region in the dihydrate of
the sodium salt of ibuprofen (Ibu-DH; Zhang & Grant, 2005).
The 3Q-MAS NMR spectra of DH-II and Ibu-DH also exhibit
partially overlapping contours, induced by similar isotropic
chemical shifts and EFG tensors (see supporting information).
As a final step to model the DH-II structure, the naphthalene
rings of both naproxen molecules in the shifted polymeric
ribbon were rotated around the C5—C11 bond to emulate the
ring positions in AH. The final model comprises Na+/carbox-
ylate/H2O regions similar to those in Ibu-DH, with naproxen
regions similar to those in AH. The broader lines in the 13C
CP/MAS NMR spectra for DH-II and lack of singularities in
the 23Na MAS NMR lineshapes (Fig. 5) indicate a higher
degree of disorder compared with both Ibu-DH and AH.
The DH-II model was subjected to DFT-D minimization in
space group P1, initially with the unit-cell parameters
constrained to those from the Pawley fit, then with the unit-
cell parameters free to optimize. The minimized structure
remained practically unchanged compared with the starting
model, verifying that it is a viable energetic minimum. Finally,
the minimized structure was used as the starting point for
Rietveld refinement against the PXRD data, producing the fit
illustrated in Fig. 10. The combination of the DFT-D mini-
mization, satisfactory Rietveld fit and close similarity of the
13C NMR for DH-II and AH provide strong evidence for the
validity of the proposed DH-II structure. The observed
‘modularity’ of the naproxen sections in AH and the Na+/
carboxylate/H2O regions in sodium
ibuprofen dihydrate provides a
further intuitive indication that the
structure is correct.
The DH-II structure also exhi-
bits extensive pseudosymmetry.
The naproxen molecules conform
approximately to space group P21,
as for AH, although DH-II contains
both molecular conformations
shown in Fig. 3. The Na+/carbox-
ylate/H2O regions alone conform
very closely to the space group P1
(as for racemic Ibu-DH; Zhang &
Grant, 2005), with a unit-cell
volume half that of the DH-II cell
(see supporting information). The
line broadening seen in the 13C
NMR, and the multiple resonances
for C11 and C13, can be attributed
to the presence of the two alter-
native molecular conformations
(Fig. 3). The resonances for C13
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Figure 10
Rietveld refinement for DH-II against laboratory PXRD data (red crosses = measured points, blue line =
calculated, black line = difference, blue ticks = Bragg peak positions). The intense low-angle (100) peak at
2	 = 3.94 was partially obscured, so is omitted from the refinement.
Figure 9
Modelling of the DH-II structure. (a) The DH-I unit cell is doubled and
transformed (without changing the DH-I structure) into a setting
comparable to that for AH. (b) One polymeric ribbon is shifted by 12b
(red = before shift; blue = after shift), and the naphthalene rings are
rotated to emulate the orientation in AH.
appear to be a superposition of the two resonances seen for
AH and the single resonance for MH (or DH-I), as would be
expected. The shoulder on the low-field side of the C14
resonance seems to be due to C11. The local environments of
all C14 methyl groups are equivalent to those in AH, so
variation in the environment of C14 does not account for this
shoulder. Instead, the splitting seen for the C11 resonance in
AH appears to be increased in DH-II so that the lower-field
C11 resonance appears as the low-field shoulder on the C14
resonance.
3.5. Structural basis for the observed hydration/dehydration
pathways
The established structures for DH-I and DH-II provide an
effective basis to rationalize the observed hydration/dehy-
dration pathways in the sodium naproxen anhydrate–hydrate
system. Both the AH$DH-II and MH$DH-I transforma-
tions can be referred to as topotactic, since they retain
comparable crystallographic lattices. The topotactic transfor-
mations should have relatively low activation energies
compared with the non-topotactic transformations, and they
are observed to operate at room temperature or below. Thus,
hydration of AH at 25C proceeds directly to DH-II, and
dehydration of DH-II under vacuum at 5C proceeds
directly to AH. Above room temperature, the non-topotactic
pathways become viable as their higher activation barriers can
be thermally overcome. Thus, AH transforms sequentially to
MH then to DH-I at 50C, while dehydration of DH-II at 40C
produces mainly MH. In this respect, it is notable that DH-II
can be stored indefinitely at 25C/55% relative humidity,
where the non-topotactic pathways are not accessible.
However, DH-II undergoes transformation to DH-I if it is
stored at 50C/80% relative humidity.
In thermogravimetric analysis (TGA; Fig. 11), both DH-I
and DH-II show an intermediate plateau corresponding to
MH, but the shapes of the TGA curves are different, and they
exhibit a different dependence on the heating rate (Fig. 11).
For DH-I, the shape of the curve remains qualitatively similar
at heating rates of 1, 5 or 10C min1, with the plateau
occurring consistently around 93% weight, as expected for
MH. For DH-II, the shape of the curve changes as a function
of heating rate. As the heating rate is decreased, the plateau
becomes less pronounced, and it moves progressively to lower
weight %.
With the established structural information, we interpret
the TGA data as follows:
(i) For DH-I, topotactic transformation to MH operates
initially, while non-topotactic transformation to AH is acti-
vated only above a threshold temperature. In the TGA curve
at 1C min1 the DH-I!MH transformation is essentially
complete by 40C, then the MH! AH transformation begins
just below 50C. Thus, the curve at 1C min1 approaches a
step function. At higher heating rates, the plateau is less well
defined because the non-topotactic MH ! AH transforma-
tion is activated before the DH-I ! MH transformation is
complete (i.e.MH that is formed can transform immediately to
AH).
(ii) For DH-II, topotactic transformation to AH operates
initially, while the non-topotactic pathway viaMH is activated
only above a threshold temperature. At 1C min1, the DH-II
! AH transformation is almost complete before the non-
topotactic threshold temperature is reached, so the plateau for
MH is small and it appears at a lower weight % because the
MH produced from the DH-II that remains at that time
comprises only a small fraction of the total sample. At higher
heating rates, the non-topotactic pathway is activated while
there is still a significant amount of DH-II present, so the
plateau for MH appears more pronounced and closer to the
expected 93 wt %.
(iii) Malaj et al. (2009) have previously reported two-step
dehydration for DH-I and one-step dehydration for DH-II.
They noted that the first step for DH-I has a comparable
kinetic profile to the single step for DH-II. We interpret this as
the kinetic profile for topotactic dehydration. The second-step
dehydration of DH-I was fitted by Malaj et al. to a different
empirical rate equation with the implication of a different
physical mechanism. We interpret this as the non-topotactic
dehydration of MH to AH.
For dehydration of DH-II to AH, it is interesting to
consider the sequential DH-II!MH! AH pathway, which
involves two non-topotactic steps and operates above room
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Figure 11
Thermogravimetric analysis (TGA) measured for (a) DH-I and (b) DH-
II at heating rates 1, 5 and 10C min1.
temperature. For the DH-II ! MH step, we might speculate
on whether the transformation occurs directly, or sequentially
via DH-I. Conceptually, this depends on the rate for re-
arrangement of the naproxen molecules from edge-on (in DH-
II) to parallel (in DH-I), compared with the rate at which the
water stoichiometry changes from dihydrate to monohydrate.
If the naproxen rearrangement occurs before the water stoi-
chiometry changes, the transformation proceeds via DH-I. If
the stoichiometry changes simultaneously with the naproxen
rearrangement, the transformation proceeds directly from
DH-II to MH. The DFT-D minimized structures of MH and
DH-I have essentially identical unit-cell volumes (see
supporting information), which indicates that the packing
arrangement is governed by the naproxen molecules and that
the Na+/H2O region of either MH or DH-I can be accom-
modated within the same framework of naproxen molecules.
The implication is that the hydrate stoichiometry for a crys-
talline material having the MH/DH-I structure could be
continuously variable between MH and DH. In this case, the
distinction between direct DH-II! MH or sequential DH-II
! DH-I ! MH transformation has little practical meaning,
and the process is better represented as DH-II ! [DH-I $
MH]. There is also a possibility that the water stoichiometry
could change from DH to MH before any naproxen rearran-
gement occurs. This would produce a polymorph of MH
having the edge-on naproxen structure (i.e. ‘MH-II’). We
examined this possibility using PXRD and ss-NMR under
various in situ dehydration conditions, but we did not find any
evidence for such a phase. Likewise, we did not find any
evidence for an AH phase having a parallel naproxen
arrangement.
4. Conclusions
The structural data provided here for the sodium naproxen
anhydrate–hydrate system enable us to rationalize the
complex transformation pathways that have previously been
observed. The key is to establish the topotactic and non-
topotactic nature of the various transformations. For this
exercise to be effective, it is clearly important to have struc-
tural information for all involved solid phases. For DH-II in
particular, the required solid-state preparation route hinders
growth of suitable single crystals, and the combined modelling/
PXRD/S-NMR approach becomes crucially important.
Although the experimental and computational effort required
to apply these techniques is significantly greater than that for a
contemporary single-crystal X-ray analysis, the rewards for
understanding systems of this type are significant.
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